nodes	percent_of_prediction	percent_of_DWPC	metapath
Bexarotene—CYP3A4—Fingolimod—multiple sclerosis	0.0766	0.223	CbGbCtD
Bexarotene—CYP3A4—Methylprednisolone—multiple sclerosis	0.0494	0.144	CbGbCtD
Bexarotene—CYP3A4—Triamcinolone—multiple sclerosis	0.0374	0.109	CbGbCtD
Bexarotene—CYP3A4—Mitoxantrone—multiple sclerosis	0.036	0.105	CbGbCtD
Bexarotene—CYP2C9—Dexamethasone—multiple sclerosis	0.0321	0.0934	CbGbCtD
Bexarotene—CYP3A4—Betamethasone—multiple sclerosis	0.0321	0.0934	CbGbCtD
Bexarotene—CYP3A4—Prednisolone—multiple sclerosis	0.0317	0.0921	CbGbCtD
Bexarotene—CYP3A4—Prednisone—multiple sclerosis	0.0299	0.087	CbGbCtD
Bexarotene—RXRB—Vitamin D Metabolism—CYP24A1—multiple sclerosis	0.0215	0.107	CbGpPWpGaD
Bexarotene—RXRB—Vitamin D Metabolism—CYP27B1—multiple sclerosis	0.0215	0.107	CbGpPWpGaD
Bexarotene—CYP3A4—Dexamethasone—multiple sclerosis	0.0187	0.0543	CbGbCtD
Bexarotene—RXRA—Vitamin D Metabolism—CYP24A1—multiple sclerosis	0.0112	0.0558	CbGpPWpGaD
Bexarotene—RXRA—Vitamin D Metabolism—CYP27B1—multiple sclerosis	0.0112	0.0558	CbGpPWpGaD
Bexarotene—RXRB—Vitamin D Metabolism—VDR—multiple sclerosis	0.00703	0.035	CbGpPWpGaD
Bexarotene—RXRG—Nuclear Receptors—PGR—multiple sclerosis	0.00368	0.0183	CbGpPWpGaD
Bexarotene—RXRA—Vitamin D Metabolism—VDR—multiple sclerosis	0.00367	0.0183	CbGpPWpGaD
Bexarotene—RXRG—RXR and RAR heterodimerization with other nuclear receptor—VDR—multiple sclerosis	0.00348	0.0173	CbGpPWpGaD
Bexarotene—RXRB—Nuclear Receptors—PGR—multiple sclerosis	0.00346	0.0172	CbGpPWpGaD
Bexarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—VDR—multiple sclerosis	0.00327	0.0163	CbGpPWpGaD
Bexarotene—RXRG—Retinoic acid receptors-mediated signaling—VDR—multiple sclerosis	0.00311	0.0155	CbGpPWpGaD
Bexarotene—RXRB—Retinoic acid receptors-mediated signaling—VDR—multiple sclerosis	0.00292	0.0145	CbGpPWpGaD
Bexarotene—RXRG—Nuclear Receptor transcription pathway—PGR—multiple sclerosis	0.00291	0.0145	CbGpPWpGaD
Bexarotene—RXRB—Nuclear Receptor transcription pathway—PGR—multiple sclerosis	0.00273	0.0136	CbGpPWpGaD
Bexarotene—RXRA—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.00267	0.0133	CbGpPWpGaD
Bexarotene—RXRA—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.00267	0.0133	CbGpPWpGaD
Bexarotene—RXRG—Nuclear Receptors—VDR—multiple sclerosis	0.00257	0.0128	CbGpPWpGaD
Bexarotene—RXRB—Nuclear Receptors—VDR—multiple sclerosis	0.00242	0.012	CbGpPWpGaD
Bexarotene—RXRA—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.00217	0.0108	CbGpPWpGaD
Bexarotene—RXRA—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.00217	0.0108	CbGpPWpGaD
Bexarotene—RXRG—Nuclear Receptor transcription pathway—VDR—multiple sclerosis	0.00203	0.0101	CbGpPWpGaD
Bexarotene—RXRB—Nuclear Receptor transcription pathway—VDR—multiple sclerosis	0.00191	0.00951	CbGpPWpGaD
Bexarotene—RXRA—Nuclear Receptors—PGR—multiple sclerosis	0.0018	0.00898	CbGpPWpGaD
Bexarotene—RXRA—RXR and RAR heterodimerization with other nuclear receptor—VDR—multiple sclerosis	0.00171	0.0085	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—ZNF746—multiple sclerosis	0.00166	0.00829	CbGpPWpGaD
Bexarotene—RXRG—medulla oblongata—multiple sclerosis	0.00159	0.0991	CbGeAlD
Bexarotene—RXRA—Recycling of bile acids and salts—ALB—multiple sclerosis	0.00158	0.00786	CbGpPWpGaD
Bexarotene—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.00157	0.00783	CbGpPWpGaD
Bexarotene—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.00157	0.00783	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—ZNF746—multiple sclerosis	0.00156	0.00779	CbGpPWpGaD
Bexarotene—RXRA—Retinoic acid receptors-mediated signaling—VDR—multiple sclerosis	0.00152	0.00758	CbGpPWpGaD
Bexarotene—RXRG—midbrain—multiple sclerosis	0.00146	0.0906	CbGeAlD
Bexarotene—RXRA—Nuclear Receptor transcription pathway—PGR—multiple sclerosis	0.00142	0.0071	CbGpPWpGaD
Bexarotene—RXRG—spinal cord—multiple sclerosis	0.00142	0.0884	CbGeAlD
Bexarotene—RXRG—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—multiple sclerosis	0.00138	0.00688	CbGpPWpGaD
Bexarotene—RXRA—nervous system—multiple sclerosis	0.00136	0.0848	CbGeAlD
Bexarotene—RXRA—central nervous system—multiple sclerosis	0.00131	0.0817	CbGeAlD
Bexarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—multiple sclerosis	0.0013	0.00647	CbGpPWpGaD
Bexarotene—RXRA—Endogenous sterols—POMC—multiple sclerosis	0.00129	0.00645	CbGpPWpGaD
Bexarotene—RXRG—RXR and RAR heterodimerization with other nuclear receptor—TNF—multiple sclerosis	0.00129	0.00642	CbGpPWpGaD
Bexarotene—RXRA—Nuclear Receptors—VDR—multiple sclerosis	0.00126	0.00627	CbGpPWpGaD
Bexarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TNF—multiple sclerosis	0.00121	0.00604	CbGpPWpGaD
Bexarotene—RXRG—Retinoic acid receptors-mediated signaling—MAPK1—multiple sclerosis	0.00121	0.00601	CbGpPWpGaD
Bexarotene—RXRG—nervous system—multiple sclerosis	0.0012	0.0745	CbGeAlD
Bexarotene—RXRG—central nervous system—multiple sclerosis	0.00115	0.0717	CbGeAlD
Bexarotene—RXRA—Biological oxidations—CYP27B1—multiple sclerosis	0.00115	0.00573	CbGpPWpGaD
Bexarotene—RXRA—Biological oxidations—CYP24A1—multiple sclerosis	0.00115	0.00573	CbGpPWpGaD
Bexarotene—RXRB—Retinoic acid receptors-mediated signaling—MAPK1—multiple sclerosis	0.00114	0.00566	CbGpPWpGaD
Bexarotene—RXRB—nervous system—multiple sclerosis	0.00112	0.07	CbGeAlD
Bexarotene—RXRB—central nervous system—multiple sclerosis	0.00108	0.0674	CbGeAlD
Bexarotene—RXRB—cerebellum—multiple sclerosis	0.00106	0.0659	CbGeAlD
Bexarotene—RXRA—brain—multiple sclerosis	0.00104	0.0648	CbGeAlD
Bexarotene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.00104	0.00516	CbGpPWpGaD
Bexarotene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.00104	0.00516	CbGpPWpGaD
Bexarotene—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000997	0.00497	CbGpPWpGaD
Bexarotene—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000997	0.00497	CbGpPWpGaD
Bexarotene—RXRA—Nuclear Receptor transcription pathway—VDR—multiple sclerosis	0.000995	0.00496	CbGpPWpGaD
Bexarotene—CYP2C9—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000984	0.0049	CbGpPWpGaD
Bexarotene—CYP2C9—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000984	0.0049	CbGpPWpGaD
Bexarotene—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.000917	0.00457	CbGpPWpGaD
Bexarotene—RXRG—brain—multiple sclerosis	0.000915	0.0569	CbGeAlD
Bexarotene—RXRG—Vitamin A and Carotenoid Metabolism—MAPK1—multiple sclerosis	0.000905	0.00451	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—CD24—multiple sclerosis	0.000861	0.00429	CbGpPWpGaD
Bexarotene—RXRB—brain—multiple sclerosis	0.00086	0.0535	CbGeAlD
Bexarotene—RXRB—Vitamin A and Carotenoid Metabolism—MAPK1—multiple sclerosis	0.000851	0.00424	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—FAS—multiple sclerosis	0.000838	0.00417	CbGpPWpGaD
Bexarotene—RXRA—Bile acid and bile salt metabolism—ALB—multiple sclerosis	0.000825	0.00411	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—ZNF746—multiple sclerosis	0.000816	0.00406	CbGpPWpGaD
Bexarotene—CYP2C9—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000809	0.00403	CbGpPWpGaD
Bexarotene—CYP2C9—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000809	0.00403	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.000802	0.00399	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—ZNF746—multiple sclerosis	0.000801	0.00399	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—ZNF746—multiple sclerosis	0.000753	0.00375	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—PTBP1—multiple sclerosis	0.000733	0.00365	CbGpPWpGaD
Bexarotene—RXRA—Transcription factor regulation in adipogenesis—TNF—multiple sclerosis	0.000722	0.0036	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—PTBP1—multiple sclerosis	0.000689	0.00343	CbGpPWpGaD
Bexarotene—RXRA—PPAR Alpha Pathway—MYC—multiple sclerosis	0.000678	0.00338	CbGpPWpGaD
Bexarotene—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—multiple sclerosis	0.000677	0.00337	CbGpPWpGaD
Bexarotene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000658	0.00328	CbGpPWpGaD
Bexarotene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000658	0.00328	CbGpPWpGaD
Bexarotene—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000649	0.00323	CbGpPWpGaD
Bexarotene—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000649	0.00323	CbGpPWpGaD
Bexarotene—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TNF—multiple sclerosis	0.000632	0.00315	CbGpPWpGaD
Bexarotene—RXRA—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000601	0.00299	CbGpPWpGaD
Bexarotene—RXRA—Retinoic acid receptors-mediated signaling—MAPK1—multiple sclerosis	0.000592	0.00295	CbGpPWpGaD
Bexarotene—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.00059	0.00294	CbGpPWpGaD
Bexarotene—RXRA—Transcription factor regulation in adipogenesis—IL6—multiple sclerosis	0.000583	0.0029	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—HNRNPA1—multiple sclerosis	0.000555	0.00277	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—U2AF2—multiple sclerosis	0.000555	0.00277	CbGpPWpGaD
Bexarotene—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000533	0.00266	CbGpPWpGaD
Bexarotene—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000533	0.00266	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—HNRNPA1—multiple sclerosis	0.000522	0.0026	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—U2AF2—multiple sclerosis	0.000522	0.0026	CbGpPWpGaD
Bexarotene—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000514	0.00256	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—PGR—multiple sclerosis	0.000502	0.0025	CbGpPWpGaD
Bexarotene—RXRA—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000487	0.00243	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—PGR—multiple sclerosis	0.000472	0.00235	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000452	0.00225	CbGpPWpGaD
Bexarotene—RXRA—Vitamin A and Carotenoid Metabolism—MAPK1—multiple sclerosis	0.000444	0.00221	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000442	0.0022	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000442	0.0022	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	0.000439	0.00219	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—ZFP36L1—multiple sclerosis	0.000439	0.00219	CbGpPWpGaD
Bexarotene—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	0.00043	0.00214	CbGpPWpGaD
Bexarotene—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	0.00043	0.00214	CbGpPWpGaD
Bexarotene—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000424	0.00211	CbGpPWpGaD
Bexarotene—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000424	0.00211	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—ZFP36L1—multiple sclerosis	0.000413	0.00206	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—STAT3—multiple sclerosis	0.000411	0.00205	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—FAS—multiple sclerosis	0.000411	0.00205	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—ZNF746—multiple sclerosis	0.000393	0.00196	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—TGFB1—multiple sclerosis	0.000381	0.0019	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—PTBP1—multiple sclerosis	0.000359	0.00179	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—TNF—multiple sclerosis	0.000356	0.00177	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	0.000353	0.00176	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—VDR—multiple sclerosis	0.000351	0.00175	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000342	0.00171	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—PABPC1—multiple sclerosis	0.00034	0.0017	CbGpPWpGaD
Bexarotene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000339	0.00169	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—VDR—multiple sclerosis	0.00033	0.00164	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—PABPC1—multiple sclerosis	0.00032	0.00159	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—RPL5—multiple sclerosis	0.000307	0.00153	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	0.000302	0.0015	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—RPL5—multiple sclerosis	0.000289	0.00144	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—IL6—multiple sclerosis	0.000287	0.00143	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—PRNP—multiple sclerosis	0.000284	0.00142	CbGpPWpGaD
Bexarotene—RXRA—Transcriptional regulation of white adipocyte differentiation—TGFB1—multiple sclerosis	0.000284	0.00141	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000283	0.00141	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000283	0.00141	CbGpPWpGaD
Bexarotene—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000279	0.00139	CbGpPWpGaD
Bexarotene—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000279	0.00139	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—SRM—multiple sclerosis	0.000279	0.00139	CbGpPWpGaD
Bexarotene—Stomatitis—Methotrexate—multiple sclerosis	0.000273	0.000623	CcSEcCtD
Bexarotene—Angiopathy—Prednisone—multiple sclerosis	0.000273	0.000622	CcSEcCtD
Bexarotene—Conjunctivitis—Methotrexate—multiple sclerosis	0.000273	0.000621	CcSEcCtD
Bexarotene—Confusional state—Methylprednisolone—multiple sclerosis	0.000273	0.000621	CcSEcCtD
Bexarotene—RXRA—Gene Expression—U2AF2—multiple sclerosis	0.000272	0.00136	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—HNRNPA1—multiple sclerosis	0.000272	0.00136	CbGpPWpGaD
Bexarotene—Malaise—Dexamethasone—multiple sclerosis	0.000272	0.000618	CcSEcCtD
Bexarotene—Malaise—Betamethasone—multiple sclerosis	0.000272	0.000618	CcSEcCtD
Bexarotene—Oedema—Triamcinolone—multiple sclerosis	0.000271	0.000617	CcSEcCtD
Bexarotene—RXRA—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000271	0.00135	CbGpPWpGaD
Bexarotene—Vertigo—Betamethasone—multiple sclerosis	0.000271	0.000616	CcSEcCtD
Bexarotene—Vertigo—Dexamethasone—multiple sclerosis	0.000271	0.000616	CcSEcCtD
Bexarotene—Syncope—Betamethasone—multiple sclerosis	0.00027	0.000615	CcSEcCtD
Bexarotene—Syncope—Dexamethasone—multiple sclerosis	0.00027	0.000615	CcSEcCtD
Bexarotene—Arrhythmia—Prednisone—multiple sclerosis	0.000269	0.000613	CcSEcCtD
Bexarotene—Infection—Triamcinolone—multiple sclerosis	0.000269	0.000613	CcSEcCtD
Bexarotene—Sweating—Methotrexate—multiple sclerosis	0.000269	0.000612	CcSEcCtD
Bexarotene—Infection—Methylprednisolone—multiple sclerosis	0.000269	0.000611	CcSEcCtD
Bexarotene—Haematuria—Methotrexate—multiple sclerosis	0.000267	0.000609	CcSEcCtD
Bexarotene—Shock—Triamcinolone—multiple sclerosis	0.000267	0.000607	CcSEcCtD
Bexarotene—Insomnia—Prednisolone—multiple sclerosis	0.000266	0.000607	CcSEcCtD
Bexarotene—Alopecia—Prednisone—multiple sclerosis	0.000266	0.000606	CcSEcCtD
Bexarotene—Shock—Methylprednisolone—multiple sclerosis	0.000266	0.000606	CcSEcCtD
Bexarotene—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000265	0.000604	CcSEcCtD
Bexarotene—RXRA—Transcriptional regulation of white adipocyte differentiation—TNF—multiple sclerosis	0.000265	0.00132	CbGpPWpGaD
Bexarotene—Loss of consciousness—Betamethasone—multiple sclerosis	0.000265	0.000603	CcSEcCtD
Bexarotene—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000265	0.000603	CcSEcCtD
Bexarotene—Epistaxis—Methotrexate—multiple sclerosis	0.000265	0.000602	CcSEcCtD
Bexarotene—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000265	0.000602	CcSEcCtD
Bexarotene—Paraesthesia—Prednisolone—multiple sclerosis	0.000265	0.000602	CcSEcCtD
Bexarotene—Tachycardia—Triamcinolone—multiple sclerosis	0.000264	0.000602	CcSEcCtD
Bexarotene—Nausea—Azathioprine—multiple sclerosis	0.000264	0.000601	CcSEcCtD
Bexarotene—Tachycardia—Methylprednisolone—multiple sclerosis	0.000264	0.000601	CcSEcCtD
Bexarotene—Skin disorder—Methylprednisolone—multiple sclerosis	0.000263	0.000598	CcSEcCtD
Bexarotene—Malnutrition—Prednisone—multiple sclerosis	0.000262	0.000597	CcSEcCtD
Bexarotene—Erythema—Prednisone—multiple sclerosis	0.000262	0.000597	CcSEcCtD
Bexarotene—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000262	0.000596	CcSEcCtD
Bexarotene—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000261	0.000595	CcSEcCtD
Bexarotene—Hypertension—Dexamethasone—multiple sclerosis	0.00026	0.000592	CcSEcCtD
Bexarotene—Hypertension—Betamethasone—multiple sclerosis	0.00026	0.000592	CcSEcCtD
Bexarotene—RXRA—Biological oxidations—POMC—multiple sclerosis	0.000259	0.00129	CbGpPWpGaD
Bexarotene—Asthenia—Mitoxantrone—multiple sclerosis	0.000258	0.000587	CcSEcCtD
Bexarotene—Myalgia—Dexamethasone—multiple sclerosis	0.000256	0.000584	CcSEcCtD
Bexarotene—Myalgia—Betamethasone—multiple sclerosis	0.000256	0.000584	CcSEcCtD
Bexarotene—Anxiety—Betamethasone—multiple sclerosis	0.000256	0.000582	CcSEcCtD
Bexarotene—Anxiety—Dexamethasone—multiple sclerosis	0.000256	0.000582	CcSEcCtD
Bexarotene—Discomfort—Dexamethasone—multiple sclerosis	0.000253	0.000577	CcSEcCtD
Bexarotene—Discomfort—Betamethasone—multiple sclerosis	0.000253	0.000577	CcSEcCtD
Bexarotene—Haemoglobin—Methotrexate—multiple sclerosis	0.000253	0.000576	CcSEcCtD
Bexarotene—CYP3A4—nervous system—multiple sclerosis	0.000252	0.0157	CbGeAlD
Bexarotene—Pain—Prednisolone—multiple sclerosis	0.000252	0.000574	CcSEcCtD
Bexarotene—Haemorrhage—Methotrexate—multiple sclerosis	0.000252	0.000573	CcSEcCtD
Bexarotene—Pharyngitis—Methotrexate—multiple sclerosis	0.00025	0.000569	CcSEcCtD
Bexarotene—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000249	0.000566	CcSEcCtD
Bexarotene—Urethral disorder—Methotrexate—multiple sclerosis	0.000247	0.000562	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000247	0.000562	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000246	0.000561	CcSEcCtD
Bexarotene—RXRA—Generic Transcription Pathway—PGR—multiple sclerosis	0.000246	0.00123	CbGpPWpGaD
Bexarotene—Oedema—Betamethasone—multiple sclerosis	0.000246	0.00056	CcSEcCtD
Bexarotene—Oedema—Dexamethasone—multiple sclerosis	0.000246	0.00056	CcSEcCtD
Bexarotene—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000246	0.000559	CcSEcCtD
Bexarotene—Insomnia—Triamcinolone—multiple sclerosis	0.000245	0.000558	CcSEcCtD
Bexarotene—Insomnia—Methylprednisolone—multiple sclerosis	0.000245	0.000557	CcSEcCtD
Bexarotene—Infection—Betamethasone—multiple sclerosis	0.000244	0.000556	CcSEcCtD
Bexarotene—Infection—Dexamethasone—multiple sclerosis	0.000244	0.000556	CcSEcCtD
Bexarotene—Ill-defined disorder—Prednisone—multiple sclerosis	0.000243	0.000554	CcSEcCtD
Bexarotene—Paraesthesia—Triamcinolone—multiple sclerosis	0.000243	0.000554	CcSEcCtD
Bexarotene—Feeling abnormal—Prednisolone—multiple sclerosis	0.000243	0.000553	CcSEcCtD
Bexarotene—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000243	0.000553	CcSEcCtD
Bexarotene—CYP3A4—central nervous system—multiple sclerosis	0.000243	0.0151	CbGeAlD
Bexarotene—Anaemia—Prednisone—multiple sclerosis	0.000242	0.000552	CcSEcCtD
Bexarotene—Shock—Betamethasone—multiple sclerosis	0.000242	0.000551	CcSEcCtD
Bexarotene—Shock—Dexamethasone—multiple sclerosis	0.000242	0.000551	CcSEcCtD
Bexarotene—RXRG—Gene Expression—PGR—multiple sclerosis	0.000242	0.0012	CbGpPWpGaD
Bexarotene—Dyspnoea—Triamcinolone—multiple sclerosis	0.000242	0.00055	CcSEcCtD
Bexarotene—Nervous system disorder—Betamethasone—multiple sclerosis	0.000241	0.000549	CcSEcCtD
Bexarotene—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000241	0.000549	CcSEcCtD
Bexarotene—Agitation—Prednisone—multiple sclerosis	0.000241	0.000549	CcSEcCtD
Bexarotene—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000241	0.000548	CcSEcCtD
Bexarotene—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000241	0.000548	CcSEcCtD
Bexarotene—Tachycardia—Betamethasone—multiple sclerosis	0.00024	0.000546	CcSEcCtD
Bexarotene—Tachycardia—Dexamethasone—multiple sclerosis	0.00024	0.000546	CcSEcCtD
Bexarotene—RXRA—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000239	0.00119	CbGpPWpGaD
Bexarotene—Dyspepsia—Triamcinolone—multiple sclerosis	0.000239	0.000543	CcSEcCtD
Bexarotene—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000238	0.000542	CcSEcCtD
Bexarotene—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000238	0.000541	CcSEcCtD
Bexarotene—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000238	0.000541	CcSEcCtD
Bexarotene—Malaise—Prednisone—multiple sclerosis	0.000237	0.000539	CcSEcCtD
Bexarotene—Vertigo—Prednisone—multiple sclerosis	0.000236	0.000537	CcSEcCtD
Bexarotene—Eye disorder—Methotrexate—multiple sclerosis	0.000235	0.000536	CcSEcCtD
Bexarotene—Syncope—Prednisone—multiple sclerosis	0.000235	0.000536	CcSEcCtD
Bexarotene—Tinnitus—Methotrexate—multiple sclerosis	0.000235	0.000535	CcSEcCtD
Bexarotene—Anorexia—Betamethasone—multiple sclerosis	0.000234	0.000534	CcSEcCtD
Bexarotene—Anorexia—Dexamethasone—multiple sclerosis	0.000234	0.000534	CcSEcCtD
Bexarotene—Cardiac disorder—Methotrexate—multiple sclerosis	0.000234	0.000532	CcSEcCtD
Bexarotene—Fatigue—Triamcinolone—multiple sclerosis	0.000234	0.000532	CcSEcCtD
Bexarotene—Fatigue—Methylprednisolone—multiple sclerosis	0.000233	0.000531	CcSEcCtD
Bexarotene—Pain—Triamcinolone—multiple sclerosis	0.000232	0.000528	CcSEcCtD
Bexarotene—Loss of consciousness—Prednisone—multiple sclerosis	0.000231	0.000525	CcSEcCtD
Bexarotene—Angiopathy—Methotrexate—multiple sclerosis	0.000228	0.00052	CcSEcCtD
Bexarotene—Vomiting—Mitoxantrone—multiple sclerosis	0.000228	0.00052	CcSEcCtD
Bexarotene—RXRB—Gene Expression—PGR—multiple sclerosis	0.000227	0.00113	CbGpPWpGaD
Bexarotene—Hypertension—Prednisone—multiple sclerosis	0.000226	0.000516	CcSEcCtD
Bexarotene—Rash—Mitoxantrone—multiple sclerosis	0.000226	0.000516	CcSEcCtD
Bexarotene—Dermatitis—Mitoxantrone—multiple sclerosis	0.000226	0.000515	CcSEcCtD
Bexarotene—Chills—Methotrexate—multiple sclerosis	0.000226	0.000514	CcSEcCtD
Bexarotene—Headache—Mitoxantrone—multiple sclerosis	0.000225	0.000512	CcSEcCtD
Bexarotene—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000224	0.00112	CbGpPWpGaD
Bexarotene—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000224	0.00051	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000224	0.00051	CcSEcCtD
Bexarotene—Myalgia—Prednisone—multiple sclerosis	0.000223	0.000508	CcSEcCtD
Bexarotene—Arthralgia—Prednisone—multiple sclerosis	0.000223	0.000508	CcSEcCtD
Bexarotene—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000223	0.000508	CcSEcCtD
Bexarotene—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000223	0.000507	CcSEcCtD
Bexarotene—Anxiety—Prednisone—multiple sclerosis	0.000223	0.000507	CcSEcCtD
Bexarotene—Alopecia—Methotrexate—multiple sclerosis	0.000223	0.000507	CcSEcCtD
Bexarotene—Insomnia—Dexamethasone—multiple sclerosis	0.000222	0.000506	CcSEcCtD
Bexarotene—Insomnia—Betamethasone—multiple sclerosis	0.000222	0.000506	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000222	0.000505	CcSEcCtD
Bexarotene—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000221	0.000503	CcSEcCtD
Bexarotene—RXRA—Developmental Biology—PTPRC—multiple sclerosis	0.000221	0.0011	CbGpPWpGaD
Bexarotene—Paraesthesia—Betamethasone—multiple sclerosis	0.000221	0.000503	CcSEcCtD
Bexarotene—Paraesthesia—Dexamethasone—multiple sclerosis	0.000221	0.000503	CcSEcCtD
Bexarotene—Discomfort—Prednisone—multiple sclerosis	0.000221	0.000502	CcSEcCtD
Bexarotene—Erythema—Methotrexate—multiple sclerosis	0.000219	0.000499	CcSEcCtD
Bexarotene—Malnutrition—Methotrexate—multiple sclerosis	0.000219	0.000499	CcSEcCtD
Bexarotene—Hypersensitivity—Prednisolone—multiple sclerosis	0.000217	0.000494	CcSEcCtD
Bexarotene—Dyspepsia—Betamethasone—multiple sclerosis	0.000216	0.000493	CcSEcCtD
Bexarotene—Dyspepsia—Dexamethasone—multiple sclerosis	0.000216	0.000493	CcSEcCtD
Bexarotene—RXRA—Gene Expression—ZFP36L1—multiple sclerosis	0.000215	0.00107	CbGpPWpGaD
Bexarotene—Dysgeusia—Methotrexate—multiple sclerosis	0.000215	0.000489	CcSEcCtD
Bexarotene—Body temperature increased—Triamcinolone—multiple sclerosis	0.000214	0.000488	CcSEcCtD
Bexarotene—Oedema—Prednisone—multiple sclerosis	0.000214	0.000487	CcSEcCtD
Bexarotene—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000214	0.000487	CcSEcCtD
Bexarotene—Decreased appetite—Dexamethasone—multiple sclerosis	0.000214	0.000487	CcSEcCtD
Bexarotene—Decreased appetite—Betamethasone—multiple sclerosis	0.000214	0.000487	CcSEcCtD
Bexarotene—Nausea—Mitoxantrone—multiple sclerosis	0.000213	0.000486	CcSEcCtD
Bexarotene—Infection—Prednisone—multiple sclerosis	0.000213	0.000484	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000212	0.000483	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000212	0.000483	CcSEcCtD
Bexarotene—Back pain—Methotrexate—multiple sclerosis	0.000212	0.000483	CcSEcCtD
Bexarotene—Fatigue—Betamethasone—multiple sclerosis	0.000212	0.000483	CcSEcCtD
Bexarotene—Fatigue—Dexamethasone—multiple sclerosis	0.000212	0.000483	CcSEcCtD
Bexarotene—Shock—Prednisone—multiple sclerosis	0.000211	0.00048	CcSEcCtD
Bexarotene—Pain—Dexamethasone—multiple sclerosis	0.00021	0.000479	CcSEcCtD
Bexarotene—Pain—Betamethasone—multiple sclerosis	0.00021	0.000479	CcSEcCtD
Bexarotene—Nervous system disorder—Prednisone—multiple sclerosis	0.00021	0.000478	CcSEcCtD
Bexarotene—Tachycardia—Prednisone—multiple sclerosis	0.000209	0.000476	CcSEcCtD
Bexarotene—Skin disorder—Prednisone—multiple sclerosis	0.000208	0.000473	CcSEcCtD
Bexarotene—Hyperhidrosis—Prednisone—multiple sclerosis	0.000207	0.000471	CcSEcCtD
Bexarotene—Anorexia—Prednisone—multiple sclerosis	0.000204	0.000465	CcSEcCtD
Bexarotene—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000203	0.000463	CcSEcCtD
Bexarotene—Anaemia—Methotrexate—multiple sclerosis	0.000203	0.000461	CcSEcCtD
Bexarotene—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000203	0.000461	CcSEcCtD
Bexarotene—Feeling abnormal—Betamethasone—multiple sclerosis	0.000203	0.000461	CcSEcCtD
Bexarotene—RXRA—Adipogenesis—STAT3—multiple sclerosis	0.000201	0.001	CbGpPWpGaD
Bexarotene—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000201	0.000458	CcSEcCtD
Bexarotene—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000201	0.000458	CcSEcCtD
Bexarotene—Hypersensitivity—Triamcinolone—multiple sclerosis	0.0002	0.000454	CcSEcCtD
Bexarotene—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000199	0.000453	CcSEcCtD
Bexarotene—Malaise—Methotrexate—multiple sclerosis	0.000198	0.00045	CcSEcCtD
Bexarotene—Vertigo—Methotrexate—multiple sclerosis	0.000197	0.000448	CcSEcCtD
Bexarotene—RXRA—Metabolism—CYP27B1—multiple sclerosis	0.000197	0.00098	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CYP24A1—multiple sclerosis	0.000197	0.00098	CbGpPWpGaD
Bexarotene—Leukopenia—Methotrexate—multiple sclerosis	0.000196	0.000447	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000195	0.000444	CcSEcCtD
Bexarotene—Dizziness—Prednisolone—multiple sclerosis	0.000195	0.000444	CcSEcCtD
Bexarotene—Asthenia—Triamcinolone—multiple sclerosis	0.000194	0.000443	CcSEcCtD
Bexarotene—Body temperature increased—Betamethasone—multiple sclerosis	0.000194	0.000442	CcSEcCtD
Bexarotene—Abdominal pain—Betamethasone—multiple sclerosis	0.000194	0.000442	CcSEcCtD
Bexarotene—Body temperature increased—Dexamethasone—multiple sclerosis	0.000194	0.000442	CcSEcCtD
Bexarotene—Abdominal pain—Dexamethasone—multiple sclerosis	0.000194	0.000442	CcSEcCtD
Bexarotene—Asthenia—Methylprednisolone—multiple sclerosis	0.000194	0.000442	CcSEcCtD
Bexarotene—Insomnia—Prednisone—multiple sclerosis	0.000194	0.000441	CcSEcCtD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000192	0.000958	CbGpPWpGaD
Bexarotene—Paraesthesia—Prednisone—multiple sclerosis	0.000192	0.000438	CcSEcCtD
Bexarotene—Pruritus—Triamcinolone—multiple sclerosis	0.000192	0.000436	CcSEcCtD
Bexarotene—Cough—Methotrexate—multiple sclerosis	0.000191	0.000436	CcSEcCtD
Bexarotene—Pruritus—Methylprednisolone—multiple sclerosis	0.000191	0.000435	CcSEcCtD
Bexarotene—Dyspepsia—Prednisone—multiple sclerosis	0.000188	0.000429	CcSEcCtD
Bexarotene—RXRA—Adipogenesis—TGFB1—multiple sclerosis	0.000187	0.00093	CbGpPWpGaD
Bexarotene—Chest pain—Methotrexate—multiple sclerosis	0.000187	0.000425	CcSEcCtD
Bexarotene—Arthralgia—Methotrexate—multiple sclerosis	0.000187	0.000425	CcSEcCtD
Bexarotene—Myalgia—Methotrexate—multiple sclerosis	0.000187	0.000425	CcSEcCtD
Bexarotene—Decreased appetite—Prednisone—multiple sclerosis	0.000186	0.000424	CcSEcCtD
Bexarotene—Rash—Prednisolone—multiple sclerosis	0.000186	0.000423	CcSEcCtD
Bexarotene—Dermatitis—Prednisolone—multiple sclerosis	0.000186	0.000423	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000185	0.000422	CcSEcCtD
Bexarotene—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000185	0.000421	CcSEcCtD
Bexarotene—Fatigue—Prednisone—multiple sclerosis	0.000185	0.00042	CcSEcCtD
Bexarotene—Headache—Prednisolone—multiple sclerosis	0.000185	0.00042	CcSEcCtD
Bexarotene—Discomfort—Methotrexate—multiple sclerosis	0.000184	0.00042	CcSEcCtD
Bexarotene—Constipation—Prednisone—multiple sclerosis	0.000183	0.000417	CcSEcCtD
Bexarotene—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000182	0.000906	CbGpPWpGaD
Bexarotene—Confusional state—Methotrexate—multiple sclerosis	0.00018	0.000411	CcSEcCtD
Bexarotene—RXRA—Metabolism—GPC5—multiple sclerosis	0.00018	0.000896	CbGpPWpGaD
Bexarotene—Dizziness—Triamcinolone—multiple sclerosis	0.000179	0.000408	CcSEcCtD
Bexarotene—Dizziness—Methylprednisolone—multiple sclerosis	0.000179	0.000407	CcSEcCtD
Bexarotene—Infection—Methotrexate—multiple sclerosis	0.000178	0.000405	CcSEcCtD
Bexarotene—Feeling abnormal—Prednisone—multiple sclerosis	0.000176	0.000402	CcSEcCtD
Bexarotene—Asthenia—Dexamethasone—multiple sclerosis	0.000176	0.000402	CcSEcCtD
Bexarotene—Asthenia—Betamethasone—multiple sclerosis	0.000176	0.000402	CcSEcCtD
Bexarotene—Nervous system disorder—Methotrexate—multiple sclerosis	0.000175	0.0004	CcSEcCtD
Bexarotene—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000175	0.000399	CcSEcCtD
Bexarotene—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000175	0.000399	CcSEcCtD
Bexarotene—Nausea—Prednisolone—multiple sclerosis	0.000175	0.000398	CcSEcCtD
Bexarotene—RXRA—Adipogenesis—TNF—multiple sclerosis	0.000174	0.000868	CbGpPWpGaD
Bexarotene—Pruritus—Betamethasone—multiple sclerosis	0.000174	0.000396	CcSEcCtD
Bexarotene—Pruritus—Dexamethasone—multiple sclerosis	0.000174	0.000396	CcSEcCtD
Bexarotene—Skin disorder—Methotrexate—multiple sclerosis	0.000174	0.000396	CcSEcCtD
Bexarotene—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000173	0.000394	CcSEcCtD
Bexarotene—Vomiting—Triamcinolone—multiple sclerosis	0.000172	0.000392	CcSEcCtD
Bexarotene—RXRA—Generic Transcription Pathway—VDR—multiple sclerosis	0.000172	0.000856	CbGpPWpGaD
Bexarotene—Vomiting—Methylprednisolone—multiple sclerosis	0.000172	0.000391	CcSEcCtD
Bexarotene—Rash—Triamcinolone—multiple sclerosis	0.000171	0.000389	CcSEcCtD
Bexarotene—Dermatitis—Triamcinolone—multiple sclerosis	0.000171	0.000389	CcSEcCtD
Bexarotene—Anorexia—Methotrexate—multiple sclerosis	0.000171	0.000388	CcSEcCtD
Bexarotene—Rash—Methylprednisolone—multiple sclerosis	0.00017	0.000388	CcSEcCtD
Bexarotene—Dermatitis—Methylprednisolone—multiple sclerosis	0.00017	0.000388	CcSEcCtD
Bexarotene—RXRA—NRF2 pathway—TGFB1—multiple sclerosis	0.00017	0.000847	CbGpPWpGaD
Bexarotene—Headache—Triamcinolone—multiple sclerosis	0.00017	0.000386	CcSEcCtD
Bexarotene—Headache—Methylprednisolone—multiple sclerosis	0.000169	0.000386	CcSEcCtD
Bexarotene—Abdominal pain—Prednisone—multiple sclerosis	0.000169	0.000385	CcSEcCtD
Bexarotene—Body temperature increased—Prednisone—multiple sclerosis	0.000169	0.000385	CcSEcCtD
Bexarotene—RXRG—Gene Expression—VDR—multiple sclerosis	0.000169	0.000841	CbGpPWpGaD
Bexarotene—Diarrhoea—Dexamethasone—multiple sclerosis	0.000168	0.000383	CcSEcCtD
Bexarotene—Diarrhoea—Betamethasone—multiple sclerosis	0.000168	0.000383	CcSEcCtD
Bexarotene—RXRA—Gene Expression—PABPC1—multiple sclerosis	0.000167	0.000831	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000165	0.000821	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000165	0.000821	CbGpPWpGaD
Bexarotene—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000163	0.000371	CcSEcCtD
Bexarotene—Dizziness—Dexamethasone—multiple sclerosis	0.000163	0.00037	CcSEcCtD
Bexarotene—Dizziness—Betamethasone—multiple sclerosis	0.000163	0.00037	CcSEcCtD
Bexarotene—Insomnia—Methotrexate—multiple sclerosis	0.000162	0.000368	CcSEcCtD
Bexarotene—Nausea—Triamcinolone—multiple sclerosis	0.000161	0.000366	CcSEcCtD
Bexarotene—Paraesthesia—Methotrexate—multiple sclerosis	0.000161	0.000366	CcSEcCtD
Bexarotene—Nausea—Methylprednisolone—multiple sclerosis	0.000161	0.000366	CcSEcCtD
Bexarotene—Dyspnoea—Methotrexate—multiple sclerosis	0.00016	0.000363	CcSEcCtD
Bexarotene—Somnolence—Methotrexate—multiple sclerosis	0.000159	0.000362	CcSEcCtD
Bexarotene—RXRB—Gene Expression—VDR—multiple sclerosis	0.000159	0.000791	CbGpPWpGaD
Bexarotene—Hypersensitivity—Prednisone—multiple sclerosis	0.000158	0.000359	CcSEcCtD
Bexarotene—Dyspepsia—Methotrexate—multiple sclerosis	0.000158	0.000359	CcSEcCtD
Bexarotene—Vomiting—Betamethasone—multiple sclerosis	0.000156	0.000356	CcSEcCtD
Bexarotene—Vomiting—Dexamethasone—multiple sclerosis	0.000156	0.000356	CcSEcCtD
Bexarotene—Decreased appetite—Methotrexate—multiple sclerosis	0.000156	0.000354	CcSEcCtD
Bexarotene—Rash—Dexamethasone—multiple sclerosis	0.000155	0.000353	CcSEcCtD
Bexarotene—Rash—Betamethasone—multiple sclerosis	0.000155	0.000353	CcSEcCtD
Bexarotene—Dermatitis—Betamethasone—multiple sclerosis	0.000155	0.000353	CcSEcCtD
Bexarotene—Dermatitis—Dexamethasone—multiple sclerosis	0.000155	0.000353	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000154	0.000352	CcSEcCtD
Bexarotene—Fatigue—Methotrexate—multiple sclerosis	0.000154	0.000351	CcSEcCtD
Bexarotene—Headache—Dexamethasone—multiple sclerosis	0.000154	0.000351	CcSEcCtD
Bexarotene—Headache—Betamethasone—multiple sclerosis	0.000154	0.000351	CcSEcCtD
Bexarotene—Asthenia—Prednisone—multiple sclerosis	0.000154	0.00035	CcSEcCtD
Bexarotene—Pain—Methotrexate—multiple sclerosis	0.000153	0.000348	CcSEcCtD
Bexarotene—Pruritus—Prednisone—multiple sclerosis	0.000151	0.000345	CcSEcCtD
Bexarotene—RXRA—Gene Expression—RPL5—multiple sclerosis	0.00015	0.000749	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—RRM1—multiple sclerosis	0.000149	0.000743	CbGpPWpGaD
Bexarotene—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000148	0.000737	CbGpPWpGaD
Bexarotene—Feeling abnormal—Methotrexate—multiple sclerosis	0.000147	0.000336	CcSEcCtD
Bexarotene—Diarrhoea—Prednisone—multiple sclerosis	0.000146	0.000334	CcSEcCtD
Bexarotene—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000146	0.000333	CcSEcCtD
Bexarotene—Nausea—Betamethasone—multiple sclerosis	0.000146	0.000332	CcSEcCtD
Bexarotene—Nausea—Dexamethasone—multiple sclerosis	0.000146	0.000332	CcSEcCtD
Bexarotene—Dizziness—Prednisone—multiple sclerosis	0.000142	0.000322	CcSEcCtD
Bexarotene—Body temperature increased—Methotrexate—multiple sclerosis	0.000141	0.000322	CcSEcCtD
Bexarotene—Abdominal pain—Methotrexate—multiple sclerosis	0.000141	0.000322	CcSEcCtD
Bexarotene—RXRA—Adipogenesis—IL6—multiple sclerosis	0.000141	0.000701	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—MYC—multiple sclerosis	0.000139	0.000695	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	0.000138	0.000685	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	0.000137	0.000684	CbGpPWpGaD
Bexarotene—Vomiting—Prednisone—multiple sclerosis	0.000136	0.00031	CcSEcCtD
Bexarotene—Rash—Prednisone—multiple sclerosis	0.000135	0.000307	CcSEcCtD
Bexarotene—Dermatitis—Prednisone—multiple sclerosis	0.000135	0.000307	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	0.000135	0.00067	CbGpPWpGaD
Bexarotene—Headache—Prednisone—multiple sclerosis	0.000134	0.000305	CcSEcCtD
Bexarotene—Hypersensitivity—Methotrexate—multiple sclerosis	0.000132	0.0003	CcSEcCtD
Bexarotene—RXRB—Generic Transcription Pathway—MYC—multiple sclerosis	0.000131	0.000653	CbGpPWpGaD
Bexarotene—Asthenia—Methotrexate—multiple sclerosis	0.000128	0.000292	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	0.000128	0.000638	CbGpPWpGaD
Bexarotene—Nausea—Prednisone—multiple sclerosis	0.000127	0.00029	CcSEcCtD
Bexarotene—Pruritus—Methotrexate—multiple sclerosis	0.000127	0.000288	CcSEcCtD
Bexarotene—Diarrhoea—Methotrexate—multiple sclerosis	0.000122	0.000279	CcSEcCtD
Bexarotene—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.00012	0.000597	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—PGR—multiple sclerosis	0.000118	0.00059	CbGpPWpGaD
Bexarotene—Dizziness—Methotrexate—multiple sclerosis	0.000118	0.000269	CcSEcCtD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.000116	0.000576	CbGpPWpGaD
Bexarotene—Vomiting—Methotrexate—multiple sclerosis	0.000114	0.000259	CcSEcCtD
Bexarotene—Rash—Methotrexate—multiple sclerosis	0.000113	0.000257	CcSEcCtD
Bexarotene—Dermatitis—Methotrexate—multiple sclerosis	0.000113	0.000257	CcSEcCtD
Bexarotene—Headache—Methotrexate—multiple sclerosis	0.000112	0.000255	CcSEcCtD
Bexarotene—Nausea—Methotrexate—multiple sclerosis	0.000106	0.000242	CcSEcCtD
Bexarotene—CYP2C9—Metabolism—SRM—multiple sclerosis	0.000104	0.000519	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	9.94e-05	0.000495	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—TYK2—multiple sclerosis	9.89e-05	0.000492	CbGpPWpGaD
Bexarotene—CYP2C9—Biological oxidations—POMC—multiple sclerosis	9.66e-05	0.000481	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	9.06e-05	0.000451	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—ALB—multiple sclerosis	8.62e-05	0.000429	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—BCHE—multiple sclerosis	8.56e-05	0.000427	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—VDR—multiple sclerosis	8.28e-05	0.000412	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—MMP9—multiple sclerosis	7.79e-05	0.000388	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	7.35e-05	0.000366	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	7.35e-05	0.000366	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	7.18e-05	0.000358	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—STAT3—multiple sclerosis	6.92e-05	0.000345	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—SRM—multiple sclerosis	6.88e-05	0.000342	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—MYC—multiple sclerosis	6.83e-05	0.00034	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GPC5—multiple sclerosis	6.72e-05	0.000335	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—MYC—multiple sclerosis	6.72e-05	0.000334	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—TGFB1—multiple sclerosis	6.42e-05	0.00032	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—POMC—multiple sclerosis	6.37e-05	0.000317	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—MYC—multiple sclerosis	6.31e-05	0.000314	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—MAPK1—multiple sclerosis	6.29e-05	0.000313	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—TNF—multiple sclerosis	5.99e-05	0.000298	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—RRM1—multiple sclerosis	5.57e-05	0.000277	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—APOE—multiple sclerosis	5.15e-05	0.000257	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	4.84e-05	0.000241	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	4.84e-05	0.000241	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—IL6—multiple sclerosis	4.84e-05	0.000241	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GPC5—multiple sclerosis	4.43e-05	0.000221	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—POMC—multiple sclerosis	4.43e-05	0.00022	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	4.32e-05	0.000215	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ALB—multiple sclerosis	4.04e-05	0.000201	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.71e-05	0.000185	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—RRM1—multiple sclerosis	3.67e-05	0.000183	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.38e-05	0.000168	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—MYC—multiple sclerosis	3.29e-05	0.000164	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—BCHE—multiple sclerosis	3.2e-05	0.000159	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—BCHE—multiple sclerosis	2.11e-05	0.000105	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—APOE—multiple sclerosis	1.92e-05	9.58e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—POMC—multiple sclerosis	1.65e-05	8.23e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ALB—multiple sclerosis	1.51e-05	7.5e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—APOE—multiple sclerosis	1.27e-05	6.32e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—POMC—multiple sclerosis	1.09e-05	5.43e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ALB—multiple sclerosis	9.94e-06	4.95e-05	CbGpPWpGaD
